Sensex Today Gains 467 Points to End at Record High | Finance, Banking Stocks Surge | HDFC Life Rallies 6%

Fri, 16 Jun Closing

   Previous Close   

   Pre-Open   

   10:30 am   

On Friday, Indian share markets ended on a strong note supported by broad gains across sectors after economic data from the US boosted bets that Fed may be less hawkish than expected.

Benchmark indices extended their gains as the session progressed and shot up during the closing hours, following strong gains by index heavyweight Reliance Industries.

Both the benchmark indices - BSE Sensex and NSE Nifty are trading very close to their all-time high levels.

At the closing bell, the BSE Sensex stood higher by 467 points (up 0.7%).

Meanwhile, the NSE Nifty closed higher by 138 points (up 0.7%).

Bajaj Finserv, Titan and ITC were among the top gainers today.

Wipro, TCS and Power Grid on the other hand, were among the top losers today.

Check out the NSE Nifty heatmap to get the complete list of gainers and losers.

The SGX Nifty was trading at 18,902, up by 142 points, at the time of writing.

Broader markets ended on a positive note. The BSE Midcap index ended 0.7% higher while the BSE SmallCap index gained 0.8%.

Sectoral indices ended on a mixed note with stocks in the finance sector, banking sector and capital goods sector witnessed most of the buying.

While IT stocks and realty stocks witnessed selling.

Shares of AIA Engineering and Hindustan Aeronautics hit their 52-week highs today.

Shares of Ramkrishna Forgings and Titagarh Wagons surged up to 8% and hit their respective record highs after their consortium won a contract to supply 1.54 million forged wheels to the government.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

Asian stock markets ended on a positive note after the Bank of Japan maintained its ultra-easy monetary policy.

The Nikkei ended the day higher by 0.6%, while the Hang Seng rallied 1%. The Shanghai Composite ended 0.6% higher.

European shares were also higher on Friday as gains were led by defensive healthcare stocks at the end of a week dominated by major central bank policy decisions.

The rupee is trading at 81.91 against the US$.

Gold prices for the latest contract on MCX are trading 0.3% higher at Rs 59,489 per 10 grams.

Meanwhile, silver prices for the latest contract on MCX are trading 0.5% higher at Rs 72,473 per kg.

Speaking of stock markets, the stock price of US tech company Nvidia soared by 25% after the management predicted a massive boom in demand for its computer chips in the latest earnings call.

The company expects to meet the needs of AI products such as ChatGPT.

Can Indian investors profit from such AI led boom in stock markets?

Co-head of Research at Equitymaster Tanushree Banerjee, answers this in the video below.

TCS & Transamerica End Partnership

Tata Consultancy Services (TCS) has ended its US$ 2 billion (bn) deal with the American arm of Dutch insurer Aegon NV's subsidiary Transamerica Life Insurance.

The 10-year deal, signed in January 2018, has come to an end as Transamerica plans to cut its dependence on third-party IT services firms such as TCS.

The IT major worked for Transamerica life insurance, annuities, supplemental health insurance and other employee benefit products.

Transamerica was supposed to rapidly enhance its digital capabilities and simplify the service of more than 10 million policies into a single, integrated modern platform through the deal.

This development comes at a time when TCS is staring in a slowdown. This makes it a challenging start for chief executive K. Krithivasan, who only took over as the boss on 1 June 2023 after his predecessor Rajesh Gopinathan resigned.

As a part of TCS's January 2018 agreement with Transamerica, the IT major hired about 2,000 people who were formerly employed by Transamerica in the US.

Tata Consultancy Services (TCS) is a bright shining star in the galaxy of Tata Group companies.

TCS has been one of the favourite stocks of investors because of the performance it has delivered since its listing.

If you had invested Rs 1 lakh in TCS shares at the issue price of Rs 850 in the IPO in 2004, the value of that investment today would be around Rs 3,176,000, a return of almost 3,000% by August 2022.

With strong fundamentals, it stands among the 5 best long-term companies of 2023.

IKIO Lighting Soars on Debut

Shares of IKIO Lighting made a stellar debut on the bourses on Friday as they listed at Rs 392.5 on NSE, a premium of 37.7% or Rs 107.5 over the issue price of Rs 285.

The stock got listed at Rs 391 on BSE, up 37.19%, as against the offer price. Ahead of the listing, the shares were commanding a premium of around Rs 99 in the unlisted market.

The net proceeds from the public offer will be used to repay borrowings, invest in its subsidiary IKIO Solutions for setting up a new facility in Noida and other general corporate purposes.

The Rs 6.1 bn IPO, with a fresh issue of Rs 3.5 bn and an offer of sale (OFS) of 90 lakh equity shares, had received tremendous a response from investors, making it one of the most successful primary market issues of the year.

The issue was subscribed by a whopping 67 times. While the qualified institutional buyers (QIBs) category was subscribed 163.5 times, the portion for non-institutional investors received 63.3 times bids, and the retail investors' quota got subscribed by 13.8 times.

IKIO Lighting designs, develops, manufactures and supplies products to customers under their own brands.

For more details, check out the current IPOs and upcoming IPOs on our website.

NATCO's Generic Lonsurf Gets USFDA Approval

Natco Pharma on Friday received final approval for its Abbreviated New Drug Application (ANDA) for Tipiracil Hydrochloride and Trifluridine Tablets (generic for Lonsurf) from the US Food and Drug Administration (USFDA).

Lonsurf is sold in the US by Taiho Oncology.

Natco believes it is one of the first-to-file for the product and may be eligible for a 180-day exclusivity period at the time of launch.

Lonsurf is indicated primarily for the treatment of colorectal cancer. As per IQVIA data, Lonsurf had generated annual sales of US$ 211 million (m) in the US during the twelve months ending December 2022.

Check out Equitymaster's stock screener for screening India's top pharma stocks.

And to know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers